Health Condition 1: null- PREMENSTRUAL SYNDROME
Conditions
Interventions
Intervention1: Qust: Fine Powder of Qust 3gm orally in capsules form ( 3 cap. twice a day)
Control Intervention1: Sumbul-ut-teeb: Fine powder of Sumbul-ut-teeb 3gm orally in capsule form ( 3 cap. twi
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Patients with regular cycle and a cycle length of 21- 35 days presenting with signs and symptoms of premenstrual syndrome Symptoms only during the premenstrual period with marked relief at onset of menstruation PMTS-O with VAS scale
Exclusion criteria
Exclusion criteria: Patients on hormonal replacement therapy, oral contraceptive, undergone hysterectomy Diagnosed cases of pschyiatric disorder, lactating mother Present with any organic pelvic pathology, irregular menstrual cycle Patients with any systemic and metabolic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient presenting with â?¥1 of the following symptoms. Depression, irritability, anxiety, angry outburst, confusion, social withdrawal, breast tenderness, abdominal bloating and pain , headache, swelling of extremities Timepoint: 15 days prior to expected date of mentruation for 2 cycles | — |
Secondary
| Measure | Time frame |
|---|---|
| Premenstrual tension scale- self rating with VAS scale(PMTS-SR with VAS)12, SF-12 SCORE Timepoint: 15 days prior to expected date of mentruation for 2 cycles | — |
Countries
India
Contacts
Public ContactDr Wajeeha Begum
Rajiv Gandhi University of Health and Sciences
Outcome results
None listed